[기고] 에버그리닝 특허 전략, 다양한 형태와 명암

- () ȣ

Ư ⺻ ߸ ϰ ν ϴ , ڿԴ ׿ ϴ Ⱓ οϴ ̴. Ư ࡤ̿ Ư ġ ߿ϱ ̷ 'Ư' ߿伺 ſ ũٰ ִ. ׷ Ư Ⱓ 20̰, Ǿǰ ִ 5 ̸ ϴ(ֱ Ư ̿ ̽ ִ).

IMS Institute for Healthcare Informatics ߰ (Price Declines after Branded Medicines Lose Exclusivity in the U.S) , (Ư) ǵ 1 ̳ డ 51% . 10 ִ 88% ߴ. ǰ 㰡 ȭ, ű ž ̵ ϰ ׿ ϴµ, Ư Ǵ డ ϹǷ ȸ鿡Դ ӱⰣ ᰡ ġ ۿѴ. Ư ῡ ս ִ ϰ ϴ ۿ .

ټ ȸ Ư㰡 DZ ļ Ư㸦 δ Ư Ⱓ ϴ Ͱ ȿ Ѵ. ׸ ǰ, ϸ Ⱓ ø ε, ̸ '׸(Evergreening) Ư '̶ Ѵ.

޿׸ Ư پ

Ư ȣϰ R&D() ϴ , ׸ ٸ ۿ ִ. Ǵ پ Ȱ Ư ȣ Ⱓ ϰ ִµ, ֿ .

(Formulation) : ּ , 汸 Ǵ ֻ ο Ư㸦
뵵(Indication) : ġ ̿ܿ ο (Ǿ ӻ) Ư㸦
(Composition) : ȿ ϰ ̿ ο Ư㸦
(Process) : ๰ ȭ Ư㸦
뺹(Combination Therapy): Ǿǰ ٸ Ȱ а ȿɡȿ ο Ư㸦

ǥ ʷδ Ʊ׶(Viagra) (Lipitor) ִ. Ʊ׶ ̱ ȸ ȭڿ ߵ Ʊ׶ ġ. ׷ ӻ ߱ ġ ȿ Ӱ ߰ߵư ȭڴ 뵵 Ӱ Ư㸦 ûߴ. ̿ Ư ̾ 2012 3 2019 10 7Ⱓ ƴ. ̸ ߱ ġ 92% ϴ â ־. ȭ ġ 2007 5 õ Ư㰡 ƴ. ׷ ϱ Ư㸦 ӻ󿡼 3 ֱ⿡ ļ Ư㸦 ߴ. ̼ü Ư, Ư, Ư ϴ Ư Ŀ ϱ پ õߴ.

޿׸ Ư

Ƿ 籹 , ׸ Ư Ѵ. Ϻ 鿡 ָ ŷ̳ Ư Ϸ õ , ׸ Ư ִٴ ϱ ƴ.

: ȸ 忡 ű Ư㸦 Ȯ ְ ̸ ο ߿ ִ ȯ ȴ. ž ߿ ð ҿǹǷ ؼ ʿϴٴ 嵵 Ѵ. ȯ(Һ) ִ. ǥ ๰ Ǽ ϰų ۿ پ 찡 ̿ شѴ. ܼ ƴ ǰ ȯ ǥ Ѵٸ ̴ ִ ̴.

: ʹ ݴ ȯڵ ظ ִ. ļ Ư ׸ , ̿ Ǿǰ ϰ ȴ. ȯڵ üǰ ̿ ȸ ϰ Ǹ ̴ Ƿ δ ̾ ȴ. ư 鿡 սǷ ̾ ȴ. 󼭴 ￡ ָ ִ. ֱ Ư ϰ Ǵϴ ߼ Ƿ ȿȭ ɼ ִ. Ư ̶ Ǵܵȴٸ ŷ ִ. ׸ȸ Ư㹫ȿ̳ ǸȮν ϰų ƿ Ư㸦 ȸ ִ ٸ Ǵٸ ￡ ۽ ִ.

׸ Ư ࡤ̿ ͼ شȭϴ ߿ . ׷ Ӹ ƴ϶, ҺڿԵ ظ ʷ ִ. ̷ ؼ ʿϴ. ̿ Բ 鿡Դ ܼ ƴ ž ߰ Ҿ ̰ Ư 䱸 ̴.

ȣ/=()